BOULDER, Colo., Oct 28, 2002 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq:
ARRY) will report financial results for the first quarter of fiscal 2003 on
Monday, November 4, 2002, at 4:30 p.m. eastern time and hold a conference call
on Tuesday, November 5, 2002, at 9:00 a.m. eastern time. Robert E. Conway, Chief
Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead
the call.
CONFERENCE CALL INFORMATION
Date: Tuesday, November 5, 2002
Time: 9:00 a.m. eastern time
Toll-Free: (800) 967-7134
Toll: (719) 457-2625
Web Cast: www.arraybiopharma.com
There will be a replay of the conference call for one week, which can be
accessed in the United States by dialing toll-free (888) 203-1112, and outside
the United States (719) 457-0820. The access code is 146603. Replay of the call
will also be available as a web cast on Array's web site at
www.arraybiopharma.com.
Array BioPharma is a drug discovery company creating new small molecule drugs
through the integration of chemistry, biology and informatics. Our experienced
scientists use an integrated set of drug discovery technologies, which we call
the Array Discovery Platform, to invent small molecule drugs in collaboration
with leading pharmaceutical and biotechnology companies and to build our own
pipeline of proprietary drug candidates. For more information on Array
BioPharma, please visit our web site at www.arraybiopharma.com.
CONTACT: Array BioPharma Inc.
Tricia Haugeto, 303/386-1193
thaugeto@arraybiopharma.com
